This application of Hemogenyx’s humanized mice as a tool for drug development and testing forms the basis of the Company’s collaboration with the US biotech company.
Mice with colorectal cancers that did not receive antibiotics were cured after being treated with the chemotherapy CTX followed by CD4+T-cell therapy. However, with antibiotics on board, this curative effect was lost in three out of five mice three weeks after treatment,
http://jagwire.augusta.edu/archives/51704
Better in my view- we have a lot going on here more than just reformatting an existing drug - this is game changing blood cancer treatments, the last three RNS,s point to this , sit tight